NKARTA INC. - COMMON
2.6100
26-11月-24 12:02:02
15 分の遅延
株式
+0.0200
+0.77%
本日の幅
2.5300 - 2.6700
ISIN
N/A
ソース
NASDAQ
-
Nkarta Announces Updates to NKX019 and NKX101 Clinical Development Programs
07 10 2021 16:01:00 提供 Nasdaq GlobeNewswire
-
Nkarta to Present Preclinical Data from Engineered NK Cell Platform at SITC 36th Annual Meeting
01 10 2021 08:08:00 提供 Nasdaq GlobeNewswire
-
Nkarta to Participate at Upcoming Investor Conference
14 9 2021 08:32:00 提供 Nasdaq GlobeNewswire
-
Nkarta Reports Second Quarter 2021 Financial Results and Business Progress
12 8 2021 16:02:00 提供 Nasdaq GlobeNewswire
-
Nkarta Establishes New Combined NK Cell Therapy Manufacturing Facility / Company Headquarters
14 7 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
Nkarta to Present at Upcoming Investor Conference
16 6 2021 07:00:00 提供 Nasdaq GlobeNewswire
-
Nkarta Therapeutics CEO, Paul Hastings, Named BIO Chair for 2021-2022 Term
14 6 2021 07:01:00 提供 Nasdaq GlobeNewswire
-
Nkarta Announces June 2021 Investor Conference Schedule
25 5 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Nkarta Reports First Quarter 2021 Financial Results and Business Progress
13 5 2021 16:02:00 提供 Nasdaq GlobeNewswire
-
28 4 2021 08:02:00 提供 Nasdaq GlobeNewswire
-
Nkarta Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Business Progress
25 3 2021 16:03:00 提供 Nasdaq GlobeNewswire
-
Nkarta Announces February and March 2021 Investor Conference Schedule
17 2 2021 16:03:00 提供 Nasdaq GlobeNewswire